↓ Skip to main content

Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study

Overview of attention for article published in The Journal of Headache and Pain, December 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study
Published in
The Journal of Headache and Pain, December 2021
DOI 10.1186/s10194-021-01363-y
Pubmed ID
Authors

Fabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, Carmelina Maria Costa, Bruno Colombo, Paola Torelli, Simone Quintana, Sabina Cevoli, Valentina Favoni, Florindo d’Onofrio, Gabriella Egeo, Renata Rao, Massimo Filippi, Piero Barbanti, Claudia Altamura

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 22%
Other 5 16%
Student > Ph. D. Student 2 6%
Librarian 1 3%
Student > Bachelor 1 3%
Other 4 13%
Unknown 12 38%
Readers by discipline Count As %
Medicine and Dentistry 7 22%
Neuroscience 4 13%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Arts and Humanities 2 6%
Nursing and Health Professions 1 3%
Other 1 3%
Unknown 14 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2021.
All research outputs
#16,580,416
of 25,182,110 outputs
Outputs from The Journal of Headache and Pain
#1,108
of 1,514 outputs
Outputs of similar age
#281,348
of 513,475 outputs
Outputs of similar age from The Journal of Headache and Pain
#24
of 32 outputs
Altmetric has tracked 25,182,110 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,514 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.4. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,475 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.